InvestorsHub Logo
Followers 1
Posts 150
Boards Moderated 0
Alias Born 02/05/2014

Re: None

Thursday, 07/06/2017 3:17:51 AM

Thursday, July 06, 2017 3:17:51 AM

Post# of 6939
EBIO is somewhat a new bio company. Has several drugs in its pipeline, but Vicinium is the only one in P3 for bladder cancer. Like to know what the prospect of a positive result is? The rest of the pipeline are either in P1 or pre-clinical. It has a long way to go, but at the price, it is a good speculative play imo. Any thoughts on its future growth potential as a bio co. Thanks.